Gene Therapy for Wet AMD: Phase 1/2 Clinical Trial Results
Wednesday, December 11 2024 | 10 h 01 min | News
A new study published in The Lancet shared results from a Phase 1/2 clinical trial testing a one-time anti-VEGF gene therapy for wet...
Read More
New Treatment Target for AMD Identified
Tuesday, July 9 2024 | 13 h 35 min | Vision Science
For people living with wet age-related macular degeneration (AMD), the first line of treatment is anti-VEGF injections Anti-VEGF injections have...
Read More
